Etonogestrel

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Etonogestrel
Etonogestrel.png
Systematic (IUPAC) name
(8S,9R,10S,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
Clinical data
AHFS/Drugs.com Multum Consumer Information
MedlinePlus a604032
Legal status Prescription Only (S4) (AU) POM (UK) -only (US) Prescription only
Routes Subdermal as slow-release implant
Pharmacokinetic data
Metabolism Hepatic (P450 3A4)
Half-life 25 hours
Excretion Urinary (majority) and fecal
Identifiers
CAS number 54048-10-1 YesY
ATC code G03AC08
PubChem CID 21729469
DrugBank DB00294
ChemSpider 5292944 YesY
UNII 304GTH6RNH YesY
KEGG D04104 YesY
ChEBI CHEBI:50777 YesY
ChEMBL CHEMBL1531 YesY
Chemical data
Formula C22H28O2 
Mol. mass 324.457 g/mol
 YesY (what is this?)  (verify)

Etonogestrel is a steroidal progestin used in hormonal contraceptives, most notably the subdermal implant Nexplanon and the vaginal ring NuvaRing.

Etonogestrel is the active metabolite of the inactive prodrug desogestrel, one of two third-generation progestins found in some epidemiological studies of combined oral contraceptive pills to be associated with a higher risk of venous thrombosis than combined oral contraceptive pills containing certain second-generation progestins. Because hormones are released continuously from NuvaRing, peak and total estrogen and progestin doses are significantly lower than with combined oral contraceptives, although it is not known whether this lowers the risk of blood clots.

See also[edit]

References[edit]